BioNTech to supply modular vaccine plants to African countries

The German company BioNTech announced on February 16th its plans to supply modular plants to make mRNA vaccines to Rwanda, Senegal and, potentially, South Africa. This announcement came ahead of a Europe-Africa summit at which increasing vaccine production in Africa is expected to be a vital topic of discussion. Not only would BioNTech be responsible for the delivery and installation of the modules, but the company said it was prepared to transfer know-how to local partners to enable them to operate independently.

 While it had been previously stated that voluntary technology transfers had so far been limited during the pandemic, this was contradicted by research published end-2021, which can be found in an online report

Read the full story.